LTR 114: What QA/RA Professionals Need to Know About Rapidly Growing MedTech in India

Summary“MedTech in India is poised to generate $50 billion in revenues by 2030.”In this Let’s Talk Risk! conversation, host Naveen Agarwal engages with Sanjay Arudi, VP of Regulatory and Quality at GE Healthcare in India, to discuss the rapidly evolving MedTech environment in India. They explore the current state of the MedTech industry, government initiatives supporting healthcare, the regulatory landscape, and the importance of post-market surveillance. Sanjay shares insights on the challenges faced in regulatory compliance and offers career advice based on his extensive experience in the field. The conversation highlights India's potential to become a significant player in the global MedTech market by 2030.Listen to the full 30-minute podcast or jump to a section of interest listed below. Chapters00:20 Introducing Sanjay Arudi01:25 Current State of MedTech in India03:24 Government Initiatives and Domestic Manufacturing07:44 How Tariffs Might Impact MedTech Companies09:12 Regulatory Environment for Medical Devices14:06 Post-Market Surveillance and Reporting Requirements19:50 Regulatory Compliance Challenges in India22:33 Career Insights and Advice from Sanjay25:31 Announcements, Key Takeaways and Future OutlookIf you enjoyed this podcast, consider subscribing to the Let’s Talk Risk! newsletter.Suggested links:LTR: An exciting growth opportunity for MedTech in India. LTR: Navigating the regulatory landscape for SaMD in India. ACHIEVE: FMEA Workshop.Key Takeaways* India's MedTech industry is projected to generate 50 billion by 2030.* Government initiatives are crucial for expanding healthcare access.* 80% of medical devices in India are currently imported.* The CDSCO license facilitates entry into multiple markets.* Post-market surveillance is becoming increasingly important.* Regulatory compliance requires collaboration with regulators.* Transparency in reporting adverse events is essential for patient safety.* India's healthcare market is rapidly evolving post-COVID.* Investments in domestic manufacturing are on the rise.* Career success in regulatory roles requires active contribution and solution-oriented thinking.KeywordsMedTech, India, healthcare, regulatory environment, government initiatives, post-market surveillance, medical devices, industry growth, career advice, healthcare innovationAbout Sanjay ArudiSanjay Arudi is the Vice President of Regulatory and Quality at GE Healthcare. He has over 30 years of professional experience in engineering, management and senior leadership roles. His expertise includes product transfers, program management, implementation of Quality & Regulatory requirements across Design, Sourcing, Manufacturing, Install Base & Commercial activities. He has many years of experience in working with global regulators in creating a compliant & friendly manufacturing environment. He holds a Bachelor’s degree in Polymer Science & Technology. Let’s Talk Risk! with Dr. Naveen Agarwal is a weekly live audio event on LinkedIn, where we talk about risk management related topics in a casual, informal way. Join us at 11:00 am EST every Friday on LinkedIn.DisclaimerInformation and insights presented in this podcast are for educational purposes only, and not as legal advice. Views expressed by all speakers are their own and do not reflect those of their respective organizations.Parts of this article were created using AI-generated content, which was subsequently reviewed, edited, and fact-checked by the author to ensure accuracy and alignment with our standards. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit naveenagarwalphd.substack.com/subscribe